Anti-WWOX Antibody

WW domain-containing oxidoreductase (WWOX) is also called Fragile site FRA16D oxidoreductase (FOR). WWOX is a putative oxidoreductase that functions as a tumor suppressor and is involved in apoptosis. WWOX is also required for normal bone development, and inhibits Wnt signaling. WWOX is widely expressed, but is most strongly expressed in testis, prostate, and ovary as well as in cancer cell lines. Certain isoforms (Isoform 5 and isoform 6) are thought to only be expressed in tumor cell lines. WWOX is linked to several cancer types like Esophageal cancer (ESCR).

~56/36/20 kDa observed. Uncharacterized band(s) may appear in some lysates.

Epitope: N-Terminus

KLH-conjugated linear peptide corresponding to the N-Terminus of human WWOX.

Anti-WWOX Antibody is a highly specific rabbit polyclonal antibody, that targets WWOX & has been tested in western blotting & IHC (Paraffin).

Immunohistochemistry Analysis: A 1:500 dilution from a representative lot detected WWOX in human prostate cancer sections and human ovary sections tissue.

Research Category
Neuroscience

Research Sub Category
Developmental Signaling

Affinity purified

Purified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Stable for 1 year at 2-8°C from date of receipt.

Evaluated by Western Blotting in HepG2 cell lysate.

Western Blotting Analysis: 0.1 µg/mL of this antibody detected WWOX in 10 µg of HepG2 cell lysate.

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.